Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

SUMMARY

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement

Author(s): Genovefa D. Kolovou*, Gerald F. Watts, Dimitri P. Mikhailidis, Pablo Pérez-Martínez, Samia Mora, Helen Bilianou, George Panotopoulos, Niki Katsiki, Teik C. Ooi, José Lopez-Miranda, Anne Tybjærg-Hansen, Nicholas Tentolouris and Børge G. Nordestgaard

Volume 17, Issue 5, 2019

Page: [538 - 540] Pages: 3

DOI: 10.2174/1570161117999190517115432

« Previous
Graphical Abstract
[1]
Grundy SM, Stone NJ, Bailey AL, et al. 2018.AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ ASPC/NLA/PCNA guideline on the management of blood cholesterol: Executive summary: A report of the American college of cardiology/ American heart association task force on clinical practice guidelines. J Am Coll Cardiol 2018; pii S0735-1097(18):39033-8.
[2]
Kolovou GD, Mikhailidis DP, Kovar J, et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: An expert panel statement. Curr Vasc Pharmacol 2011; 9: 258-70.
[3]
Mihas C, Kolovou GD, Mikhailidis DP, et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: A meta-analysis. Curr Vasc Pharmacol 2011; 9: 271-80.
[4]
Kolovou GD, Mikhailidis DP, Nordestgaard BG, Bilianou H, Panotopoulos G. Definition of postprandial lipaemia. Curr Vasc Pharmacol 2011; 9: 292-301.
[5]
Kolovou GD, Watts GF, Mikhailidis DP, et al. Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: A 2019 expert panel statement, Main Text. Curr Vasc Pharmacol 2019; 17: 498-14.
[6]
Kolovou GD, Watts GF, Mikhailidis DP, et al. postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: A 2019 expert panel statement, narrative review. Curr Vasc Pharmacol 2019; 17: 515-37.

© 2024 Bentham Science Publishers | Privacy Policy